The impacted products, when configured to use SSO, are affected by an improper authentication vulnerability. This vulnerability allows the application to accept manual entry of any active directory (AD) account provisioned in the application without supplying a password, resulting in access to the application as the supplied AD account, with all associated privileges.
References
Link | Resource |
---|---|
https://www.cisa.gov/uscert/ics/advisories/icsma-21-343-01 | Mitigation Third Party Advisory US Government Resource |
https://www.cisa.gov/uscert/ics/advisories/icsma-21-343-01 | Mitigation Third Party Advisory US Government Resource |
Configurations
Configuration 1 (hide)
|
Configuration 2 (hide)
AND |
|
Configuration 3 (hide)
AND |
|
Configuration 4 (hide)
AND |
|
History
21 Nov 2024, 06:30
Type | Values Removed | Values Added |
---|---|---|
References | () https://www.cisa.gov/uscert/ics/advisories/icsma-21-343-01 - Mitigation, Third Party Advisory, US Government Resource | |
CVSS |
v2 : v3 : |
v2 : 6.8
v3 : 8.1 |
Information
Published : 2021-12-15 19:15
Updated : 2024-11-21 06:30
NVD link : CVE-2021-43935
Mitre link : CVE-2021-43935
CVE.ORG link : CVE-2021-43935
JSON object : View
Products Affected
baxter
- welch_allyn_hscribe_holter_analysis_system_firmware
- welch_allyn_q-stress_cardiac_stress_testing_system_firmware
- welch_allyn_xscribe_cardiac_stress_testing_system
- welch_allyn_connex_cardio
- welch_allyn_diagnostic_cardiology_suite
- welch_allyn_xscribe_cardiac_stress_testing_system_firmware
- welch_allyn_vision_express_holter_analysis_system
- welch_allyn_q-stress_cardiac_stress_testing_system
- welch_allyn_hscribe_holter_analysis_system
- welch_allyn_rscribe_resting_ecg_system